Rivaling the widely popular anti-aging injectables like Botox or Daxxify, a new neuromodulator has arrived State-side after years of use overseas. Letybo could give competitors a run for their ...

Hailing from South Korea, Letybo is the sixth and most recent neuromodulator approved by the FDA. Here, dermatologists unpack its benefits and key FYIs.

Before Letybo was approved, there were five neuromodulators available to injectors in the US: Botox, Xeomin, Dysport, Daxxify, and Jeuveau. Each one is formulated with botulinum toxin A, which ...

Letybo (letibotulinumtoxinA-wlbg) is now available for the temporary improvement in the appearance of moderate to severe glabellar lines.

Letybo is now fully commercialized in the U.S. through the partnership between BENEV and Hugel, marking a significant milestone in the neuromodulator market. As only the 6th neuromodulator to gain ...

The Letybo ® submission in Europe is based on the data of three completed randomized, placebo-controlled phase III trials that enrolled more than 1000 subjects in the US and Europe. National ...

Letybo has held the #1 position in South Korea for seven consecutive years, trusted by over 31 million patients across 65+ countries.

People who get anti-wrinkle injections are being warned to look for experienced practitioners and not the cheapest deal due to cost-of-living struggles, amid dozens of reports of adverse reactions ...

Letybo: A newly manufactured neurotoxin derived from Clostridium botulinum strain CBFC26, which is isolated from canned soybeans. Its isolation and purification processes also differ to Botox.

The Hugel-manufactured Letybo has soared in popularity in South Korea, where providers “have used it zillions of times,” Dr. Roy Kim, a board-certified plastic surgeon based in San Francisco ...